Concise Manual of Hematology and Oncology

  • Dietmar P. Berger
  • Monika Engelhardt
  • Hartmut Henß
  • Roland Mertelsmann

Table of contents

  1. Front Matter
    Pages I-XXI
  2. Dietmar P. Berger, Hartmut Henß, Uwe Martens, Hartmut Bertz, Monika Engelhardt, Sebastian Fetscher
    Pages 1-38
  3. Regina Kunzmann, Michael Luebbert, Hendrik Veelken, Jürgen Scheele, Uwe Martens, Rupert Engelhardt et al.
    Pages 39-64
  4. Dietmar P. Berger, Rupert Engelhardt, Hartmut Henß, Jürgen Scheele, Claudia I. Müller, Alexandra Göbel et al.
    Pages 65-203
  5. Michael Daskalakis, Hartmut Bertz, Veronique Thierry, Claudia I. Müller, Monika Engelhardt, Antonia Müller et al.
    Pages 204-292
  6. Barbara Deschler, Cornelius Waller, Monika Engelhardt, Antonia Müller, Michael Luebbert, Jürgen Finke et al.
    Pages 293-326
  7. Jürgen Finke, Hartmut Bertz, Anna-Katharina Kaskel, Jürgen Heinz, A.K. Thomas, Dietmar P. Berger et al.
    Pages 327-399
  8. Ralph Waesch, Werner Digel, Michael Luebbert, Kristina Heining-Mikesch, Cornelius Waller, W. Lange et al.
    Pages 400-526
  9. Michael Daskalakis, Karl Henne, Hartmut Henß, Uwe Martens, Werner Digel, Rupert Engelhardt et al.
    Pages 528-780
  10. Hartmut Bertz, Hartmut Henß, Beate Lubrich
    Pages 781-801
  11. Rupert Engelhardt, Andrea Engelhardt, Frank Gärtner, Stephan Mielke, Uwe Frank
    Pages 802-822
  12. D. Behringer, Dietmar P. Berger, Werner Digel, Monika Engelhardt, Jürgen Finke, Hartmut Bertz et al.
    Pages 823-989
  13. Back Matter
    Pages 991-1002

About this book


How Do We Treat? Hematology and Oncology have seen rapid progress and advances during recent years. Increased knowledge of tumor biology, epidemiology, molecular genetics, growth reg- lation, and cellular functions has led to novel therapeutic paradigms. Targeted trea- ment approaches, antibodies, immunotherapy, and other new techniques complement classic chemotherapy, radiotherapy, and surgery. Patients are increasingly well educated as web-based information on diagnostic and therapeutic options as well as quality ma- agement and tumor outcome data are readily available. In this dynamic and fast-paced environment, it is of central importance to base clinical decisions and medical practice on the best available evidence. Continuous quality ma- agement, with clinical process documentation, standardization, and evaluation, leads to improved patient care and long-term outcomes. For these reasons, we have started to systematically capture and evaluate data on diagnosis, treatment, and outcomes of p- tients with solid tumors and hematological neoplasms at the Freiburg University Med- cal Center. We have developed standard operating procedures, clinical pathways, and diagnostic and therapeutic processes, following the principles of “Good Clinical Pra- tice.” Tese processes (e.g., detailed protocols for chemotherapy application, treatment fowcharts, clinical pathways) are continuously tested and validated in clinical practice.


Cancer Chemotherapy Hematology Oncology diagnostics

Editors and affiliations

  • Dietmar P. Berger
    • 1
  • Monika Engelhardt
    • 1
  • Hartmut Henß
    • 2
  • Roland Mertelsmann
    • 1
  1. 1.Department of Hematology and OncologyUniversity Medical CenterFreiburgGermany
  2. 2.Tumorzentrum Ludwig-Heilmeyer, Comprehensive Cancer CenterUniversity Medical CenterFreiburgGermany

Bibliographic information

  • DOI
  • Copyright Information Springer Berlin Heidelberg 2008
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Medicine Medicine (R0)
  • Print ISBN 978-3-540-73276-1
  • Online ISBN 978-3-540-73277-8
  • Buy this book on publisher's site